Source: Annual Congress 2004 - Community acquired and nosocomial pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Novovic, C. N. Meyer (Copenhagen, Denmark). Community acquired pneumonia (CAP). Mortality prediction using the BTS-rule. Eur Respir J 2004; 24: Suppl. 48, 2546

Member's Comments

No comment yet.

Related content which might interest you: Community acquired pneumonia (CAP) mortality and biomarkers Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Community acquired pneumonia (CAP) and PSI mortality risk stratification Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004 Community acquired pneumonia (CAP) 30 days mortality and biomarkers Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases? Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Clinical stability in patients with community- acquired pneumonia (CAP) Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Biological markers in hospitalised patients with community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Factors affecting treatment success in community acquired pneumonia (CAP) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Community acquired pneumonia Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Severity assessment of community acquired pneumonia (CAP) using guidelines and prediction rule Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Hyperglycaemia in children with community acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003 The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Early discharge of community acquired pneumonia (CAP) patients with community respiratory assessment services (RAS) follow up in a UK DGH Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013